1st Quarter - Report

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

Firm
Client
Income
—
Expenses
$326,687
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Recognition of Osteopathic Certification

LobbyistCovered position, as disclosed
HOLLY BIGLOW —
CHARLES CASCIO —
RAY QUINTERO —
LAURA WOOSTER —

Contacted: Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Government Accountability Office (GAO); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); White House Office; Medicare Payment Advisory Commission (MedPAC)

Taxation/Internal Revenue Code TAX

Flexible Spending Accounts; Health Savings Accounts

LobbyistCovered position, as disclosed
HOLLY BIGLOW —
CHARLES CASCIO —
RAY QUINTERO —
LAURA WOOSTER —

Contacted: Medicare Payment Advisory Commission (MedPAC); Agency for Healthcare Research & Quality (AHRQ); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Government Accountability Office (GAO); SENATE; White House Office; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Education EDU

Student Loan Financing and Re-Financing

LobbyistCovered position, as disclosed
HOLLY BIGLOW —
CHARLES CASCIO —
RAY QUINTERO —
LAURA WOOSTER —

Contacted: Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); SENATE; Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; White House Office; Government Accountability Office (GAO); Agency for Healthcare Research & Quality (AHRQ)

Medical/Disease Research/Clinical Labs MED

NIH; FDA; Agency for Health Care Quality & Research Funding

LobbyistCovered position, as disclosed
HOLLY BIGLOW —
SUSAN FRIEDMAN —
ANGELA JEANSONNE —
CAROL MONACO —
RAY QUINTERO —
LAURA WOOSTER —

Contacted: Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; SENATE; White House Office; Government Accountability Office (GAO); Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS)

Torts TOR

Professional Liability Insurance; Medical Liability Reform

LobbyistCovered position, as disclosed
HOLLY BIGLOW —
CHARLES CASCIO —
RAY QUINTERO —
LAURA WOOSTER —

Contacted: Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); White House Office; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE; Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

Medicare Physician Payments Reform. Patient access to care; Graduate Medical Education. Physician Workforce Issues. Health reform implementation (PL 111-148). Telehealth (Health Information Technology). See continuation page.S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013. H.R. 2810, SGR Repeal and Medicare Beneficiary Access Act of 2013. Pathway for SGR Reform Act of 2013.

LobbyistCovered position, as disclosed
HOLLY BIGLOW —
CHARLES CASCIO —
SUSAN FRIEDMAN —
ANGELA JEANSONNE —
CAROL MONACO —
RAY QUINTERO —
LAURA WOOSTER —

Contacted: Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); White House Office; Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO)

Bills named: H.R. 2810 (113th), S. 1871 (113th)

Medicare/Medicaid MMM

Graduate Medical Education; Health Care Quality, Patient Access to Health Care; Physician Workforce; Medicare Physician Payment Issues; Independent Payment Advisory Board. H.R. 574, The Medicare Physician Payment Innovation Act of 2013. See continuation page.S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013. H.R. 2810, SGR Repeal and Medicare Beneficiary Access Act of 2013. Pathway for SGR Reform Act of 2013.

LobbyistCovered position, as disclosed
HOLLY BIGLOW —
CHARLES CASCIO —
SUSAN FRIEDMAN —
ANGELA JEANSONNE —
CAROL MONACO —
RAY QUINTERO —
LAURA WOOSTER —

Contacted: Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Government Accountability Office (GAO); Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); White House Office; Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2810 (113th), S. 1871 (113th), H.R. 574 (113th)

Budget/Appropriations BUD

Labor HHS Appropriations

LobbyistCovered position, as disclosed
HOLLY BIGLOW —
CHARLES CASCIO —
RAY QUINTERO —
LAURA WOOSTER —

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Centers For Disease Control & Prevention (CDC); White House Office; Office of Management & Budget (OMB)

Insurance INS

Health Insurance; Professional Liability Insurance; State Insurance Marketplaces

LobbyistCovered position, as disclosed
HOLLY BIGLOW —
CHARLES CASCIO —
RAY QUINTERO —
LAURA WOOSTER —

Contacted: Office of Management & Budget (OMB); Food & Drug Administration (FDA); White House Office; Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Executive Office of the President (EOP); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.